| http://www.w3.org/ns/prov#value | - However, positive reporting bias is a real concern, and no randomized trials in renal disease existA positive reporting bias...The LUNAR trial tested RTX vs. placebo in 144 pts with class III/IV LN. RTX treatment failed to meet its efficacy end-point.
|
